Table 1.
Human papillomavirus (HPV) DNA prevalence in oral cavity of men who have sex with men
| N=151 | |||
|---|---|---|---|
| n | Per cent | 95% CI | |
| Any HPV type* | 21 | 13.9 | 8.8 to 20.5 |
| Multiple types (two or more) | 1 | 0.7 | 0.0 to 3.6 |
| Multiple HR types† (two or more) | 0 | 0.0 | 0.0 to 2.4 |
| Any bivalent vaccine types‡ | 2 | 1.3 | 0.2 to 4.7 |
| Any quadrivalent vaccine types‡ | 4 | 2.6 | 0.7 to 6.6 |
| Any nonavalent vaccine types‡ | 7 | 4.6 | 1.9 to 9.3 |
| Possible high-risk types§ | 0 | 0.0 | 0.0 to 2.4 |
| High-risk HPV types (HR-HPV)† | 9 | 6.0 | 2.8 to 11.0 |
| HPV16 | 1 | 0.7 | 0.0 to 3.6 |
| HPV18 | 1 | 0.7 | 0.0 to 3.6 |
| HPV31 | 0 | 0.0 | 0.0 to 2.4 |
| HPV33 | 1 | 0.7 | 0.0 to 3.6 |
| HPV35 | 0 | 0.0 | 0.0 to 2.4 |
| HPV39 | 0 | 0.0 | 0.0 to 2.4 |
| HPV45 | 1 | 0.7 | 0.0 to 3.6 |
| HPV51 | 1 | 0.7 | 0.0 to 3.6 |
| HPV52 | 1 | 0.7 | 0.0 to 3.6 |
| HPV56 | 3 | 2.0 | 0.4 to 5.7 |
| HPV58 | 0 | 0.0 | 0.0 to 2.4 |
| HPV59 | 0 | 0.0 | 0.0 to 2.4 |
| HPV68 | 0 | 0.0 | 0.0 to 2.4 |
| Low-risk HPV types | |||
| 6 and/or 11¶ | 3 | 2.0 | 0.4 to 5.7 |
| 6¶ | 3 | 2.0 | 0.4 to 5.7 |
| 11 | 0 | 0.0 | 0.0 to 2.4 |
*Sample reacted to the universal probe for HPV DNA.
†HR types 16/18/31/33/35/39/45/51/52/56/58/59/68 classified according to the International Agency for Research on Cancer monograph carcinogenic or probably carcinogenic.
‡Vaccine types: HPV16/18 are bivalent, HPV6/11/16/18 are quadrivalent and HPV6/11/16/18/31/33/45/52/58 are nonavalent.
§Possible high-risk types: 26/53/66/70/73/82.
¶One with co-infection with HPV18.